Amelia Zellander’s pitch at Philly’s Most Diverse Tech Hub pitch competition in October was strong and confident — enough so that she won the first-place $80,000 prize.
Those in the audience might not have imagined any of the struggles she faced to get there.
Zellander is the founder and CEO of BioLattice, a tissue engineering company developing CorneaClear, a biomaterial-based solution for cornea repairs and replacements. She’s been interested in tissue engineering since she was a teen, and pursued an undergraduate degree in biomedical science, a master’s in biotechnology and a Ph.D. in bioengineering.
READ FULL ARTICLE HERE
